These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34168443)

  • 1. A Novel Model-Based Questionnaire Based on Low-Dose CT Screening Data for Chronic Obstructive Pulmonary Disease Diagnosis in Shimane, Japan.
    Tanino A; Kawamura T; Hamaguchi M; Tanino R; Nakao M; Hotta T; Tsubata Y; Hamaguchi S; Isobe T
    Int J Chron Obstruct Pulmon Dis; 2021; 16():1823-1833. PubMed ID: 34168443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the COPD Population Screener and International Primary Care Airway Group questionnaires in a general Japanese population: the Hisayama study.
    Tsukuya G; Samukawa T; Matsumoto K; Fukuyama S; Kumamoto T; Uchida A; Koriyama C; Ninomiya T; Inoue H
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1903-9. PubMed ID: 27574414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of chronic obstructive pulmonary disease in lung cancer screening computed tomographic scans.
    Mets OM; Buckens CF; Zanen P; Isgum I; van Ginneken B; Prokop M; Gietema HA; Lammers JW; Vliegenthart R; Oudkerk M; van Klaveren RJ; de Koning HJ; Mali WP; de Jong PA
    JAMA; 2011 Oct; 306(16):1775-81. PubMed ID: 22028353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of mass screening for chronic obstructive pulmonary disease using screening questionnaires in a medical health check-up population.
    Hanibuchi M; Saijo A; Mitsuhashi A; Kajimoto T; Kitagawa T; Nishioka Y
    Respir Investig; 2022 Nov; 60(6):815-821. PubMed ID: 36057534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a self-scored persistent airflow obstruction screening questionnaire in a general Japanese population: the Hisayama study.
    Samukawa T; Matsumoto K; Tsukuya G; Koriyama C; Fukuyama S; Uchida A; Mizuno K; Miyahara H; Kiyohara Y; Ninomiya T; Inoue H
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1469-1481. PubMed ID: 28553099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A combination of the IPAG questionnaire and PiKo-6® flow meter is a valuable screening tool for COPD in the primary care setting.
    Sichletidis L; Spyratos D; Papaioannou M; Chloros D; Tsiotsios A; Tsagaraki V; Haidich AB
    Prim Care Respir J; 2011 Jun; 20(2):184-9, 1 p following 189. PubMed ID: 21597666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex Differences in the International Primary Care Airways Group Questionnaire for Screening of Chronic Obstructive Pulmonary Disease: A Retrospective, Cross-Sectional Study.
    Machiguchi H; Arizono S; Tawara Y; Oomagari M; Yanagita Y; Tanaka T; Senjyu H; Kozu R
    Int J Chron Obstruct Pulmon Dis; 2022; 17():1467-1476. PubMed ID: 35769226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic obstructive pulmonary disease prevalence and prediction in a high-risk lung cancer screening population.
    Goffin JR; Pond GR; Puksa S; Tremblay A; Johnston M; Goss G; Nicholas G; Martel S; Bhatia R; Liu G; Schmidt H; Atkar-Khattra S; McWilliams A; Tsao MS; Tammemagi MC; Lam S
    BMC Pulm Med; 2020 Nov; 20(1):300. PubMed ID: 33198781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of Self-Administered Questionnaires for Identifying Individuals at Risk of COPD in Japan: The OCEAN (Okinawa COPD casE finding AssessmeNt) Study.
    Tamaki K; Sakihara E; Miyata H; Hirahara N; Kirichek O; Tawara R; Akiyama S; Katsumata M; Haruya M; Ishii T; Simard EP; Miller BE; Tal-Singer R; Kaise T
    Int J Chron Obstruct Pulmon Dis; 2021; 16():1771-1782. PubMed ID: 34168439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Three Screening Questionnaires for Chronic Obstructive Pulmonary Disease in the Primary Care.
    Spyratos D; Haidich AB; Chloros D; Michalopoulou D; Sichletidis L
    Respiration; 2017; 93(2):83-89. PubMed ID: 28052294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. External validation of the PUMA COPD diagnostic questionnaire in a general practice sample and the PLATINO study population.
    Lopez Varela MV; Montes de Oca M; Wehrmeister FC; Rodriguez C; Ramirez L; Menezes A
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1901-1911. PubMed ID: 31692595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of the 6-minute walk test as a screening test for pulmonary arterial enlargement in COPD.
    Oki Y; Kaneko M; Fujimoto Y; Sakai H; Misu S; Mitani Y; Yamaguchi T; Yasuda H; Ishikawa A
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2869-2875. PubMed ID: 27920514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of a COPD screening questionnaire and establishment of diagnostic cut-points in a Japanese general population: the Hisayama study.
    Tsukuya G; Matsumoto K; Fukuyama S; Crawford B; Nakanishi Y; Ichinose M; Machida K; Samukawa T; Ninomiya T; Kiyohara Y; Inoue H;
    Allergol Int; 2015 Jan; 64(1):49-53. PubMed ID: 25572558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Values of Body Mass Index and Chest CT Features in the Assessment of Chronic Obstructive Pulmonary Disease].
    Li L; Liu Y; Li J; Gao JM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Feb; 42(1):55-61. PubMed ID: 32131940
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnosis of chronic obstructive pulmonary disease in lung cancer screening Computed Tomography scans: independent contribution of emphysema, air trapping and bronchial wall thickening.
    Mets OM; Schmidt M; Buckens CF; Gondrie MJ; Isgum I; Oudkerk M; Vliegenthart R; de Koning HJ; van der Aalst CM; Prokop M; Lammers JW; Zanen P; Mohamed Hoesein FA; Mali WP; van Ginneken B; van Rikxoort EM; de Jong PA
    Respir Res; 2013 May; 14(1):59. PubMed ID: 23711184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total Airway Count on Computed Tomography and the Risk of Chronic Obstructive Pulmonary Disease Progression. Findings from a Population-based Study.
    Kirby M; Tanabe N; Tan WC; Zhou G; Obeidat M; Hague CJ; Leipsic J; Bourbeau J; Sin DD; Hogg JC; Coxson HO; ; ;
    Am J Respir Crit Care Med; 2018 Jan; 197(1):56-65. PubMed ID: 28886252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of five surveys that identify individuals at risk for airflow obstruction and chronic obstructive pulmonary disease.
    Sogbetun F; Eschenbacher WL; Welge JA; Panos RJ
    Respir Med; 2016 Nov; 120():1-9. PubMed ID: 27817804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of COPD Patients at High Risk for Lung Cancer Mortality Using the COPD-LUCSS-DLCO.
    de-Torres JP; Marín JM; Casanova C; Pinto-Plata V; Divo M; Cote C; Celli BR; Zulueta JJ
    Chest; 2016 Apr; 149(4):936-42. PubMed ID: 26513409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which is the Best Screening Strategy for COPD among Smokers in Primary Care?
    Llordés M; Zurdo E; Jaén Á; Vázquez I; Pastrana L; Miravitlles M
    COPD; 2017 Feb; 14(1):43-51. PubMed ID: 27797591
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.